Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

Infection and Immunity

Volumn 74, Issue 10, 2006, Pages 5693-5702

  Valore, Erika V ^a   Wiley, Dorothy J ^b   Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CHEMOKINE; DEFENSIN; INTERLEUKIN 8; MESSENGER RNA; POLYPEPTIDE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GARDNERELLA VAGINALIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; LACTOBACILLUS; LACTOBACILLUS JENSENII; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA EPITHELIUM; VAGINITIS;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BODY FLUIDS; CYTOKINES; FEMALE; GARDNERELLA VAGINALIS; HUMANS; HYDROGEN-ION CONCENTRATION; INTERLEUKIN-8; LACTIC ACID; LACTOBACILLUS; RNA, MESSENGER; VAGINAL DOUCHING; VAGINOSIS, BACTERIAL;

EID: 33749237882     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00524-06     Document Type: Article

References (40)

1. Amsel, R., P. A. Totten, C. A. Spiegel, K. C. Chen, D. Eschenbach, and K. K. Holmes. 1983. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:14-22.
2. Aroutcheva, A. A., J. A. Simoes, and S. Faro. 2001. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infect. Dis. Obstet. Gynecol. 9:33-39.
3. Ashcroft, G. S., K. Lei, W. Jin, G. Longenecker, A. B. Kulkarni, T. Greenwell-Wild, H. Hale-Donze, G. McGrady, X. Y. Song, and S. M. Wahl. 2000. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6:1147-1153.
4. Brandtzaeg, P., T. O. Gabrielsen, I. Dale, F. Muller, M. Steinbakk, and M. K. Fagerhol. 1995. The leucocyte protein L1 (calprotectin): a putative nonspecific defense factor at epithelial surfaces. Adv. Exp. Med. Biol. 371A:201-206.
5. Cauci, S., S. Guaschino, A. D. De, S. Driussi, S. D. De, P. Penacchioni, and F. Quadrifoglio. 2003. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol. Hum. Reprod. 9:53-58.
6. Cohen, C. R., A. Duerr, N. Pruithithada, S. Rugpao, S. Hillier, P. Garcia, and K. Nelson. 1995. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 9:1093-1097.
7. Dale, B. A., J. R. Kimball, S. Krisanaprakornkit, F. Roberts, M. Robinovitch, R. O'Neal, E. V. Valore, T. Ganz, G. M. Anderson, and A. Weinberg. 2001. Localized antimicrobial peptide expression in human gingiva. J. Periodontal Res. 36:285-294.
8. Eggert-Kruse, W., I. Botz, S. Pohl, G. Rohr, and T. Strowitzki. 2000. Antimicrobial activity of human cervical mucus. Hum. Reprod. 15:778-784.
9. Ferrer, J. 2000. Vaginal candidosis: epidemiological and etiological factors. Int. J. Gynaecol. Obstet. 71(Suppl. 1):S21-S27.
10. Hester, R. A., and S. B. Kennedy. 2003. Candida infection as a risk factor for HIV transmission. J. Womens Health 12:487-494.
11. Hiemstra, P. S., R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman. 1996. Antibacterial activity of antileukoprotease. Infect. Immun. 64:4520-4524.
12. Hillier, S. L. 1998. The vaginal microbial ecosystem and resistance to HIV. AIDS Res. Hum. Retrovir. 14(Suppl. 1):S17-S21.
13. Hillier, S. L. 2005. The complexity of microbial diversity in bacterial vaginosis. N. Engl. J. Med. 353:1886-1887.
14. Klebanoff, M. A., J. R. Schwebke, J. Zhang, T. R. Nansel, K. F. Yu, and W. W. Andrews. 2004. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet. Gynecol. 104:267-272.
15. Liu, A. Y., D. Destoumieux, A. V. Wong, C. H. Park, E. V. Valore, L. Liu, and T. Ganz. 2002. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Investig. Dermatol. 118:275-281.
16. Liu, L., A. A. Roberts, and T. Ganz. 2003. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J. Immunol. 170:575-580.
17. Lollike, K., L. Kjeldsen, H. Sengelov, and N. Borregaard. 1995. Lysozyme in human neutrophils and plasma: a parameter of myelopoietic activity. Leukemia 9:159-164.
18. Luni, Y., S. Munim, R. Qureshi, and A. L. Tareen. 2005. Frequency and diagnosis of bacterial vaginosis. J. Coll. Physicians Surg. Pak. 15:270-272.
19. Ma, G., T. Greenwell-Wild, K. Lei, W. Jin, J. Swisher, N. Hardegen, C. T. Wild, and S. M. Wahl. 2004. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 200:1337-1346.
20. Martin, H. L., B. A. Richardson, P. M. Nyange, L. Lavreys, S. L. Hillier, B. Chohan, K. Mandaliya, J. O. Ndinya-Achola, J. Bwayo, and J. Kreiss. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180:1863-1868.
21. Moodley, P., C. Connolly, and A. W. Sturm. 2002. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J. Infect. Dis. 185:69-73.
22. Murthy, A. R., R. I. Lehrer, S. S. Harwig, and K. T. Miyasaki. 1993. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. 151:6291-6301.
23. Myer, L., L. Denny, R. Telerant, M. de Souza, T. C. Wright, Jr., and L. Kuhn. 2005. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J. Infect. Dis. 192:1372-1380.
24. Nisapakultorn, K., K. F. Ross, and M. C. Herzberg. 2001. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect. Immun. 69:3692-3696.
25. Ocana, V. S., A. A. Pesce De Ruiz Holgado, and M. E. Nader-Macias. 1999. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl. Environ. Microbiol. 65:5631-5635.
26. Porter, E., H. Yang, S. Yavagal, G. C. Preza, O. Murillo, H. Lima, S. Greene, L. Mahoozi, M. Klein-Patel, G. Diamond, S. Gulati, T. Ganz, P. A. Rice, and A. J. Quayle. 2005. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomalis urethritis reveal novel epithelial cell-neutrophil interactions. Infect. Immun. 73:4823-4833.
27. Porter, E. M., L. Liu, A. Oren, P. A. Anton, and T. Ganz. 1997. Localization of human intestinal defensin 5 in Paneth cell granules. Infect. Immun. 65:2389-2395.
28. Quayle, A. J., E. M. Porter, A. A. Nussbaum, Y. M. Wang, C. Brabec, K. P. Yip, and S. C. Mok. 1998. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. J. Pathol. 152:1247-1258.
29. Sadhu, K., P. A. Domingue, A. W. Chow, J. Nelligan, N. Cheng, and J. W. Costerton. 1989. Gardnerella vaginalis has a gram-positive cell-wall ultrastructure and lacks classical cell-wall lipopolysaccharide. J. Med. Microbiol. 29:229-235.
30. Sewankambo, N., R. H. Gray, M. J. Wawer, L. Paxton, D. McNaim, F. Wabwire-Mangen, D. Serwadda, C. Li, N. Kiwanuka, S. L. Hillier, L. Rabe, C. A. Gaydos, T. C. Quinn, and J. Konde-Lule. 1997. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350:546-550.
31. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
32. Singh, P. K., H. P. Jia, K. Wiles, J. Hesselberth, L. Liu, B. D. Conway, E. P. Greenberg, E. V. Valore, M. J. Welsh, T. Ganz, B. F. Tack, and P. B. J. McCray. 1998. Production of β-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95:14961-14966.
33. Singh, P. K, B. F. Tack, P. B. McCray, Jr., and M. J. Welsh. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell Mol. Physiol. 279:L799-L805.
34. Sobel, J. D. 2000. Bacterial vaginosis. Annu. Rev. Med. 51:349-356.
35. Taha, T. E., D. R. Hoover, G. A. Dallabetta, N. I. Kumwenda, L. A. Mtimavalye, L. P. Yang, G. N. Liomba, R. L. Broadhead, J. D. Chiphangwi, and P. G. Miotti. 1998. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12:1699-1706.
36. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
37. Vallor, A. C., M. A. Antonio, S. E. Hawes, and S. L. Hillier. 2001. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J. Infect. Dis. 184:1431-1436.
38. Valore, E. V., C. H. Park, S. L. Igreti, and T. Ganz. 2002. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol. 187:561-568.
39. Valore, E. V., C. H. Park, A. J. Quayle, K. R. Wiles, P. B. McCray, and T. Ganz. 1998. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Investig. 101:1633-1642.
40. Venkataraman, N., A. L. Cole, P. Svoboda, J. Pohl, and A. M. Cole. 2005. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J. Immunol. 175:7560-7567.